Altaris Capital Partners’ $1.55 Billion Acquisition of Padagis

Schiff Hardin advised Altaris Capital Partners, LLC on the deal.Altaris Capital Partners, LLC announced its acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here